tiprankstipranks
Larimar Therapeutics expects cash to provide runway into 1Q25
The Fly

Larimar Therapeutics expects cash to provide runway into 1Q25

As of December 31, 2023, the Company had cash, cash equivalents and marketable securities totaling $86.8 million, which we expect to provide runway into the first quarter of 2025.

Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>

See Insiders’ Hot Stocks on TipRanks >>

Read More on LRMR:

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100
Bitcoin

Popular Articles